Imperial Brands' sales boosted by European e-cigarette demand

May.17.2022
Imperial Brands' sales boosted by European e-cigarette demand
Imperial Brands reaches two-year high as strong sales of e-cigarettes and tobacco replacements meet yearly targets.

On May 17th, according to a report by Reuters, Imperial Brands stated on Tuesday that it is expected to achieve its annual goal due to strong sales of electronic cigarettes and heated tobacco products in Europe. This has pushed its stock price to its highest point in over two years.

 

In early trading, shares of Winston cigarettes and Backwoods cigar maker rose nearly 7%, making it the second-best performing company in the STOXX Europe 600 Euro Price Index (.STOXX).

 

Susannah Streeter, senior investment and market analyst at UK investment services company Hargreaves Lansdown, stated: "Investors seem to be breathing a sigh of relief as the company looks set to meet its annual guidance figures, due to its shift towards a five-year strategy focusing on tobacco alternatives.

 

After years of slow growth and market share loss, CEO Stefan Bomhard of Empire Company has developed a turnaround plan for 2021 focusing on its top five markets and expanding the next generation products (NGP) believed to pose lesser health hazards. These five markets - the United States, United Kingdom, Germany, Spain, and Australia - collectively account for over 70% of Empire Company's revenue.

 

Last week, Philip Morris International, a competitor of the Imperial Group, acquired Swedish Match, a smaller competitor, for $16 billion. This highlights the urgency of cigarette manufacturers in developing new and potential low-risk alternative products.

 

Driven by demand in Europe, sales of the next generation brands of the Empire, including Pulze heated tobacco and blu e-cigarettes, grew by 8.7%, reaching £101 million ($126 million). In November, the company reported that losses from the business had reduced by over 50%.

 

The Empire Company also stated that its recent withdrawal from Russia did not include terms that would allow it to buy back its business in the future, as Western companies were eager to leave the country after the invasion of Ukraine.

 

Imperial Company stated in April that investors in Russia were purchasing its business there, which contributes approximately 2% to the company's annual net sales, if merged with Ukraine.

 

During Tuesday's financial report conference call, executives stated that the deal had been finalized with "absolutely no repurchase terms included.

 

On Monday, French car manufacturer Renault announced that it will be selling the majority of its shares in automaker Avtovaz to a Russian scientific research institute for reportedly only 1 ruble, with a buyback option for Renault within 6 years. This move leaves open the possibility of Renault's return to the Russian market.

 

On Tuesday, the Empire Company reported that its adjusted net revenue for the six months ending on March 31 was approximately £3.5 billion, a 0.3% increase in fixed currency. Adjusted earnings per share also rose from 107 pence to 113 pence compared to last year.

 

Source: Reuters

 

Imperial Brands has announced that its sales for the first half of the financial year remained flat, according to a report from Reuters. The tobacco company reported revenue of £3.45 billion ($4.87 billion), which was in line with analysts' expectations. Despite the steady sales figures, the company expressed confidence in its long-term growth prospects and its ability to deliver on its strategic goals. The report also noted that Imperial Brands' rival, British American Tobacco, had reported a 3% decline in its first-quarter revenue due to pandemic-related disruptions.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles authorities searched 12 businesses and arrested 24 people during a multi-agency operation targeting illicit flavored vaping products, flavored cigarettes and counterfeit merchandise on October 22, 2026. The Los Angeles County Sheriff's Department said approximately eight tractor-trailer loads of merchandise were seized. Alleged violations involved flavored tobacco sales restrictions, tobacco licensing requirements and counterfeit trademark laws. Local, state and federal agencies participated. Authorities have not disclosed the number, brands or value of vaping products seized. Investigations remain ongoing.
Enforcement
Oct.28
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
The European Commission has clarified to 2Firsts that its proposed cardiovascular health checks would assess smoking, vaping and the use of smokeless nicotine products as part of patients’ medical histories. The Commission also said Member States may organise additional checks within their healthcare systems. In the same response, it pointed to JRC research on e-cigarettes, heated tobacco products and nicotine pouches that has fed into the evaluation of EU tobacco legislation.
Nov.09